| scholarly article | Q13442814 |
| P50 | author | Robert Gish | Q47723303 |
| P2093 | author name string | Robert J Wong | |
| P2860 | cites work | Hepatitis C virus as a systemic disease: reaching beyond the liver | Q26776387 |
| Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C | Q27477981 | ||
| Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress | Q27481013 | ||
| Prevalence of childhood and adult obesity in the United States, 2011-2012 | Q29547370 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. | Q31040495 | ||
| Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial | Q33798375 | ||
| Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more | Q34172595 | ||
| Hepatitis C virus infection and the risk of coronary disease | Q34802706 | ||
| Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. | Q35011142 | ||
| Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up | Q35090649 | ||
| Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt | Q35956085 | ||
| Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study | Q36795672 | ||
| Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis | Q37097794 | ||
| Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3 | Q37155511 | ||
| Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature | Q37847930 | ||
| Hepatitis C virus infection in USA: an estimate of true prevalence | Q37899936 | ||
| Is genotype 3 of the hepatitis C virus the new villain? | Q38155123 | ||
| Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature | Q38217418 | ||
| Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review | Q38542209 | ||
| Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes | Q38557478 | ||
| Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review | Q38679027 | ||
| Insulin resistance, steatosis and hepatitis C virus. | Q39240971 | ||
| The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. | Q39304230 | ||
| Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver | Q40392671 | ||
| Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. | Q40463023 | ||
| Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy | Q41032721 | ||
| Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States | Q41626076 | ||
| Prevalence of the metabolic syndrome in the United States, 2003-2012. | Q41729356 | ||
| Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study | Q42980807 | ||
| Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. | Q42984313 | ||
| Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection | Q42997461 | ||
| Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. | Q42999424 | ||
| Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity | Q43031928 | ||
| Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response | Q43040638 | ||
| Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. | Q43047842 | ||
| Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans | Q43048280 | ||
| Associations of chronic hepatitis C with metabolic and cardiac outcomes | Q43447385 | ||
| Hepatitis C virus infection and incident type 2 diabetes | Q44493737 | ||
| Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. | Q44643929 | ||
| Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome | Q44897636 | ||
| Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. | Q45126678 | ||
| Elevated prevalence of hepatitis C infection in users of United States veterans medical centers | Q45333283 | ||
| Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study | Q45404126 | ||
| No association between hepatitis C virus seropositivity and acute myocardial infarction | Q45413289 | ||
| Hepatitis B and C virus infection and the risk of atherosclerosis in a general population | Q45641514 | ||
| Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis | Q45733913 | ||
| Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening | Q45733968 | ||
| Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States | Q45737067 | ||
| Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States | Q45740183 | ||
| Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population | Q46085882 | ||
| Ethnic disparities in the association of body mass index with the risk of hypertension and diabetes | Q46389167 | ||
| Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. | Q46727424 | ||
| Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity | Q47911394 | ||
| Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. | Q51442516 | ||
| Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis | Q61854117 | ||
| Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta | Q78665122 | ||
| Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis | Q83334976 | ||
| P433 | issue | 5 | |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| chronic hepatitis C | Q55779873 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 293-299 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Gastroenterology & hepatology | Q26842161 |
| P1476 | title | Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection | |
| P478 | volume | 12 |
| Q37635070 | 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation. |
| Q37703437 | A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases |
| Q38638110 | Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor? |
| Q55237049 | Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors. |
| Q38654885 | Lack of Association between Hepatitis C Virus core Gene Variation 70/91aa and Insulin Resistance |
| Q47179866 | Magnesium intake and mortality due to liver diseases: Results from the Third National Health and Nutrition Examination Survey Cohort |
| Q92505744 | Management of Diabetes Mellitus in Patients with Chronic Liver Diseases |
| Q38157135 | Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities |
| Q91614139 | Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years |
Search more.